These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8290602)

  • 1. Insulin receptor substrate 1 is required for insulin-mediated mitogenic signal transduction.
    Rose DW; Saltiel AR; Majumdar M; Decker SJ; Olefsky JM
    Proc Natl Acad Sci U S A; 1994 Jan; 91(2):797-801. PubMed ID: 8290602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the insulin and insulin-like growth factor 1 mitogenic intracellular signaling pathways.
    Sasaoka T; Ishiki M; Sawa T; Ishihara H; Takata Y; Imamura T; Usui I; Olefsky JM; Kobayashi M
    Endocrinology; 1996 Oct; 137(10):4427-34. PubMed ID: 8828504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of insulin receptor substrate-1 and Shc on insulin-like growth factor I receptor signaling in early passages of cultured human fibroblasts.
    Takahashi Y; Tobe K; Kadowaki H; Katsumata D; Fukushima Y; Yazaki Y; Akanuma Y; Kadowaki T
    Endocrinology; 1997 Feb; 138(2):741-50. PubMed ID: 9003010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a functional role of Shc proteins in mitogenic signaling induced by insulin, insulin-like growth factor-1, and epidermal growth factor.
    Sasaoka T; Rose DW; Jhun BH; Saltiel AR; Draznin B; Olefsky JM
    J Biol Chem; 1994 May; 269(18):13689-94. PubMed ID: 7513704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth factor-specific regulation of insulin receptor substrate-1 expression in MCF-7 breast carcinoma cells: effects on the insulin-like growth factor signaling pathway.
    Lassarre C; Ricort JM
    Endocrinology; 2003 Nov; 144(11):4811-9. PubMed ID: 12960057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common elements in interleukin 4 and insulin signaling pathways in factor-dependent hematopoietic cells.
    Wang LM; Keegan AD; Li W; Lienhard GE; Pacini S; Gutkind JS; Myers MG; Sun XJ; White MF; Aaronson SA
    Proc Natl Acad Sci U S A; 1993 May; 90(9):4032-6. PubMed ID: 7683417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged vs transient roles for early cell cycle signaling components.
    Rose DW; Xiao S; Pillay TS; Kolch W; Olefsky JM
    Oncogene; 1998 Aug; 17(7):889-99. PubMed ID: 9780005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin receptor substrate-1 enhances growth hormone-induced proliferation.
    Liang L; Zhou T; Jiang J; Pierce JH; Gustafson TA; Frank SJ
    Endocrinology; 1999 May; 140(5):1972-83. PubMed ID: 10218944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin receptor substrate 4 supports insulin- and interleukin 4-stimulated proliferation of hematopoietic cells.
    Fantin VR; Keller SR; Lienhard GE; Wang LM
    Biochem Biophys Res Commun; 1999 Jul; 260(3):718-23. PubMed ID: 10403832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GTK tyrosine kinase-induced alteration of IRS-protein signalling in insulin producing cells.
    Annerén C; Welsh M
    Mol Med; 2002 Nov; 8(11):705-13. PubMed ID: 12520087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of the Shb SH2 domain-protein in insulin-producing cells leads to altered signaling through the IRS-1 and IRS-2 proteins.
    Welsh N; Makeeva N; Welsh M
    Mol Med; 2002 Nov; 8(11):695-704. PubMed ID: 12520086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin receptor substrate (IRS) proteins IRS-1 and IRS-2 differential signaling in the insulin/insulin-like growth factor-I pathways in fetal brown adipocytes.
    Valverde AM; Lorenzo M; Pons S; White MF; Benito M
    Mol Endocrinol; 1998 May; 12(5):688-97. PubMed ID: 9605931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signalling pathways of insulin-like growth factor-I that are augmented by cAMP in FRTL-5 cells.
    Ariga M; Nedachi T; Akahori M; Sakamoto H; Ito Y; Hakuno F; Takahashi S
    Biochem J; 2000 Jun; 348 Pt 2(Pt 2):409-16. PubMed ID: 10816436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin receptor substrate 1 mediates insulin and insulin-like growth factor I-stimulated maturation of Xenopus oocytes.
    Chuang LM; Myers MG; Seidner GA; Birnbaum MJ; White MF; Kahn CR
    Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5172-5. PubMed ID: 7685118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. Evidence from transfection studies.
    Almind K; Inoue G; Pedersen O; Kahn CR
    J Clin Invest; 1996 Jun; 97(11):2569-75. PubMed ID: 8647950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microinjection of the SH2 domain of the 85-kilodalton subunit of phosphatidylinositol 3-kinase inhibits insulin-induced DNA synthesis and c-fos expression.
    Jhun BH; Rose DW; Seely BL; Rameh L; Cantley L; Saltiel AR; Olefsky JM
    Mol Cell Biol; 1994 Nov; 14(11):7466-75. PubMed ID: 7935461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling.
    Cousin SP; Hügl SR; Myers MG; White MF; Reifel-Miller A; Rhodes CJ
    Biochem J; 1999 Dec; 344 Pt 3(Pt 3):649-58. PubMed ID: 10585851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The IRS-1 signaling system.
    White MF
    Curr Opin Genet Dev; 1994 Feb; 4(1):47-54. PubMed ID: 8193539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOCS-3 is involved in the downregulation of the acute insulin-like effects of growth hormone in rat adipocytes by inhibition of Jak2/IRS-1 signaling.
    Ridderstråle M; Amstrup J; Hilton DJ; Billestrup N; Tornqvist H
    Horm Metab Res; 2003 Mar; 35(3):169-77. PubMed ID: 12734778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin receptor substrate-4 is expressed in muscle tissue without acting as a substrate for the insulin receptor.
    Schreyer S; Ledwig D; Rakatzi I; Klöting I; Eckel J
    Endocrinology; 2003 Apr; 144(4):1211-8. PubMed ID: 12639902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.